Skip to main content
. 2018 Mar 15;15(5):7523–7530. doi: 10.3892/ol.2018.8266

Figure 2.

Figure 2.

Downregulation of AFAP1-AS1 inhibits GC cell proliferation ability. (A) RT-qPCR was performed to analyze the expression level of AFAP1-AS1 in SGC-7901, BGC-823 and MGC-803 GC cell lines and GES-1 human gastric epithelial cell line. (B) sh1AFAP1-AS1 and sh2AFAP1-AS1, shRNA expression vectors targeting AFAP1-AS1, and a negative control shRNA vector were transfected into SGC-7901 and BGC-823 cells, respectively. RT-qPCR results revealed that the sh1AFAP1-AS1 sequence had the greatest inhibitory effect. (C) Cell Counting Kit-8 assays were performed to examine SGC-7901 and BGC-823 cell proliferation rates at the indicated time points. The results were analyzed using one-way analysis of variance and Student's t-test, *P<0.05. RT-qPCR, reverse transcription-quantitative polymerase chain reaction; AFAP1-AS1, AFAP1-antisense RNA 1; GC, gastric cancer; sh, short hairpin; shNC, scrambled control shRNA.